Table 2

Description of risk factors between incident and non-incident subjects in Japanese and white men

Japanese subjects (n=175)White subjects (n=113)
Incident (n=10)Non-incident (n=165)Incident (n=15)Non-incident (n=98)
Age (years)45.4 (3.6)44.9 (2.8)44.2 (2.9)44.7 (2.9)
Body mass index (kg/m2)22.8 (1.7)23.2 (2.9)27.7 (3.1)26.2 (3.0)
Systolic blood pressure (mm Hg)140.6 (24.0)123.0 (14.0)122.7 (9.6)121.4 (11.2)
Hypertension medication (%)10.03.66.75.1
LDL-C (mmol/L)3.13 (1.13)3.34 (0.95)3.26 (0.77)3.48 (0.82)
HDL-C (mmol/L)1.42 (0.35)1.41 (0.36)1.13 (0.20)1.27 (0.31)
Triglycerides (mg/dL)1.46 (1.31, 1.64)1.48 (1.08, 1.98)1.27 (1.08, 1.91)1.36 (0.99, 1.87)
Medication for hyperlipidaemia (%)01.809.2
Glucose (mmol/L)5.83 (0.64)5.81 (0.70)5.47 (0.40)5.53 (0.48)
Diabetes (%)10.04.22.00
C reactive protein (mg/L)0.3 (0.2, 07)0.3 (0.2, 0.7)1.0 (0.7, 1.8)0.8 (0.4, 1.6)
Smoking
 Current smokers (%)60.047.909.2
 Former smokers (%)30.032.120.018.4
 Pack years of smoking21.3 (4.6, 44.1)18.0 (2.9, 28.3)0 (0, 0)0 (0, 2.1)
Alcohol
 Alcohol drinker (%)80.067.353.355.1
 Ethanol consumption (g/day)36.0 (17.0, 51.4)14.0 (2.3, 37.0)6.2 (0.8, 27.8)8.7 (1.6, 18.6)
Marine n-3 fatty acids (%)8.5 (2.6)9.1 (2.5)3.47 (1.76)3.90 (1.80)
EPA (%)1.9 (0.8)2.4 (1.1)0.81 (0.65)0.72 (0.53)
DHA (%)5.7 (1.8)5.9 (1.5)2.11 (1.27)2.42 (1.24)
Follow-up (years)6.3 (0.3)6.2 (0.4)4.7 (0.1)4.6 (0.2)
  • Values are expressed as mean (SD) or median (25th and 75th centile) for continuous variables and % for categorical variables.

  • For definitions of variables, refer to table 1.

  • DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.